United Nations. Population and Vitals Statistics Report. 2015.
IDF. IDF Diabetes Atlas, 7th edn. Brussels: International Diabetes Federation, 2015.
WHO. Global Status Report on Non-communicable Diseases 2010. Geneva: World Health Organization, 2011.
WHO. The Global Burden of Disease: 2004 Update. Geneva: World Health Organization, 2008.
Gurdasani, D, et al.
The African Genome Variation Project shapes medical genetics in Africa. Nature
2014; 517: 327–332.
Ferlay, J, et al.
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International Journal of Cancer
2010; 127: 2893–2917.
Yusuf, S, et al.
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet
2004; 364: 937–952.
Murphy, GA, et al.
Sociodemographic distribution of non-communicable disease risk factors in rural Uganda: a cross-sectional study. International Journal of Epidemiology
2013; 42: 1740–1753.
BeLue, R, et al.
An overview of cardiovascular risk factor burden in sub-Saharan African countries: a socio-cultural perspective. Globalization and Health
2009; 5: 10.
Riha, J, et al.
Urbanicity and lifestyle risk factors for cardiometabolic diseases in rural Uganda: a cross-sectional study. PLoS Medicine
2014; 11: e1001683.
Assah, FK, et al.
Urbanization, physical activity, and metabolic health in sub-Saharan Africa. Diabetes Care
2011; 34: 491–496.
Sobngwi, E, et al.
Exposure over the life course to an urban environment and its relation with obesity, diabetes, and hypertension in rural and urban Cameroon. International Journal of Epidemiology
2004; 33: 769–776.
Hawkes, C. Uneven dietary development: linking the policies and processes of globalization with the nutrition transition, obesity and diet-related chronic diseases. Globalization and Health
2006; 2: 4.
Kavishe, B, et al.
High prevalence of hypertension and of risk factors for non-communicable diseases (NCDs): a population based cross-sectional survey of NCDS and HIV infection in Northwestern Tanzania and Southern Uganda. BMC Medicine
2015; 13: 126.
Ng, M, et al.
Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet
2014; 384: 766–781.
Torloni, MR, et al.
Prepregnancy BMI and the risk of gestational diabetes: a systematic review of the literature with meta-analysis. Obesity Reviews
2009; 10: 194–203.
Yu, CK, Teoh, TG, Robinson, S. Obesity in pregnancy. British Journal of Obstetrics and Gynaecology
2006; 113: 1117–1125.
Yogev, Y, Visser, GHA. Obesity, gestational diabetes and pregnancy outcome. Seminars in Fetal and Neonatal Medicine
2009; 14: 77–84.
Wendland, EM, et al.
Gestational diabetes and pregnancy outcomes – a systematic review of the World Health Organization (WHO) and the International Association of Diabetes in Pregnancy Study Groups (IADPSG) diagnostic criteria. BMC Pregnancy and Childbirth
2012; 12: 23.
Ben-Haroush, A, Yogev, Y, Hod, M. Epidemiology of gestational diabetes mellitus and its association with Type 2 diabetes. Diabetic Medicine
2004; 21: 103–113.
Kim, C, Newton, KM, Knopp, RH. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care
2002; 25: 1862–1868.
Kaul, P, et al.
Impact of gestational diabetes mellitus and high maternal weight on the development of diabetes, hypertension and cardiovascular disease: a population-level analysis. Diabetic Medicine
2014; 32: 164–173.
Boney, CM, et al.
Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics
2005; 115: e290–e296.
Uauy, R, Kain, J, Corvalan, C. How can the Developmental Origins of Health and Disease (DOHaD) hypothesis contribute to improving health in developing countries?
American Journal of Clinical Nutrition
2011; 94(6 Suppl.): 1759s–1764s.
Barker, DJ. Fetal origins of coronary heart disease. BMJ (Clinical research ed)
1995; 311: 171–174.
Barker, DJ, et al.
Fetal nutrition and cardiovascular disease in adult life. Lancet
1993; 341: 938–941.
Gluckman, PD, Hanson, MA, Beedle, AS. Non-genomic transgenerational inheritance of disease risk. BioEssays
2007; 29: 145–154.
Barker, DJ. The origins of the developmental origins theory. Journal of Internal Medicine
2007; 261: 412–417.
Barker, DJ, Bagby, SP, Hanson, MA. Mechanisms of disease: in utero programming in the pathogenesis of hypertension. Nature Clinical Practice Nephrology
2006; 2: 700–707.
UNAIDS. How AIDS Changed Everything Report – 2015. Geneva: UNAIDS, 2015.
Pawlowski, A, et al.
Tuberculosis and HIV Co-Infection. Plos Pathogens
2012; 8: e1002464.
UNAIDS. Access to Antiretroviral Therapy in Africa; Status Report on Progress Towards the 2015 Targets. Geneva: UNAIDS, 2013.
WHO. Antimicrobial Resistance; Global Report on Surveillance. Geneva: World Health Organisation, 2014.
Okeke, IN, et al.
Antimicrobial resistance in developing countries. Part I: recent trends and current status. Lancet Infectious Diseases
2005; 5: 481–493.
Hotamisligil, GS. Inflammation and metabolic disorders. Nature
2006; 444: 860–867.
Crusz, SM, Balkwill, FR. Inflammation and cancer: advances and new agents. Nature Reviews Clinical Oncology
2015; 12: 584–596.
Young, F, et al.
A review of co-morbidity between infectious and chronic disease in Sub Saharan Africa: TB and Diabetes Mellitus, HIV and Metabolic Syndrome, and the impact of globalization. Globalization and Health
2009; 5: 9.
Dillon, DG, et al.
Association of HIV and ART with cardiometabolic traits in sub-Saharan Africa: a systematic review and meta-analysis. International Journal of Epidemiology
2013; 42: 1754–1771.
Brown, TT, et al.
Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study. Archives of Internal Medicine
2005; 165: 1179–1184.
De Wit, S, et al.
Incidence and risk factors for new-onset diabetes in HIV-infected patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study. Diabetes Care
2008; 31: 1224–1229.
Triant, VA, et al.
Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. Journal of Clinical Endocrinology and Metabolism
2007; 92: 2506–2512.
Shintani, Y, et al.
Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance. Gastroenterology
2004; 126: 840–848.
Marzouk, D, et al.
Metabolic and cardiovascular risk profiles and hepatitis C virus infection in rural Egypt. Gut
2007; 56: 1105–1110.
Wang, CS, et al.
Hepatitis C virus infection and the development of type 2 diabetes in a community-based longitudinal study. American Journal of Epidemiology
2007; 166: 196–203.
Chen, SL, Morgan, TR. The natural history of hepatitis C virus (HCV) infection. International Journal of Medical Sciences
2006; 3: 47–52.
Wang, C, et al.
Increased risk of hepatocellular carcinoma in patients with diabetes mellitus: a systematic review and meta-analysis of cohort studies. International Journal of Cancer Journal international du cancer
2012; 130: 1639–1648.
Genovese, G, et al.
Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science
2010; 329: 841–845.
Gaziano, TA, et al.
Comparative assessment of absolute cardiovascular disease risk characterization from non-laboratory-based risk assessment in South African populations. BMC Medicine
2013; 11: 170.
Motala, AA, et al.
The prevalence of metabolic syndrome and determination of the optimal waist circumference cutoff points in a rural South African community. Diabetes Care
2011; 34: 1032–1037.
Crowther, NJ, Norris, SA. The current waist circumference cut point used for the diagnosis of metabolic syndrome in Sub-Saharan African women is not appropriate. PLoS ONE
2012; 7: e48883.
Mensah, GA. Descriptive epidemiology of cardiovascular risk factors and diabetes in sub-Saharan Africa. Progress in Cardiovascular Diseases
2013; 56: 240–250.
Bonita, R. Guest editorial: strengthening NCD prevention through risk factor surveillance. Global Health Action
2009; 2: 4–6.
Murphy, GA, et al.
Cardiometabolic risk in a rural Ugandan population. Diabetes Care
2013; 36: e143.
Kahn, K, et al.
Validation and application of verbal autopsies in a rural area of South Africa. Tropical Medicine & International Health: TM & IH
2000; 5: 824–831.
Asiki, G, et al.
The general population cohort in rural south-western Uganda: a platform for communicable and non-communicable disease studies. International Journal of Epidemiology
2013; 42: 129–141.
Ng, N, et al.
Combining risk factors and demographic surveillance: potentials of WHO STEPS and INDEPTH methodologies for assessing epidemiological transition. Scandinavian Journal of Public Health
2006; 34: 199–208.
WHO. WHO STEPS Instrument (Core and Expanded): The WHO STEPwise Approach to Noncommunicable Disease Risk Factor Surveillance (STEPS). Geneva: World Health Organization, 2016.
Beran, D, Yudkin, JS. Diabetes care in sub-Saharan Africa. Lancet
2006; 368: 1689–1695.
Maseko, FC, Chirwa, ML, Muula, AS. Health systems challenges in cervical cancer prevention program in Malawi. Global Health Action
2015; 8: 26282.
Janssens, B, et al.
Offering integrated care for HIV/AIDS, diabetes and hypertension within chronic disease clinics in Cambodia. Bulletin of the World Health Organization
2007; 85: 880–885.
Atun, R, et al.
Improving responsiveness of health systems to non-communicable diseases. Lancet
2013; 381: 690–697.
van Olmen, J, et al.
Management of chronic diseases in Sub-Saharan Africa: cross-fertilisation between HIV/AIDS and diabetes care. Journal of Tropical Medicine
2012; 2012: 349312.
WHO. Package of Essenrtial Noncommunicable (PEN) Disease Interventions for Primary Health Care in Low-Resource Settings. Geneva: World Health Organization, 2010.
Beaglehole, R, et al.
Improving the prevention and management of chronic disease in low-income and middle-income countries: a priority for primary health care. Lancet
2008; 372: 940–949.
Maher, D, et al.
Research needs for an improved primary care response to chronic non-communicable diseases in Africa. Tropical Medicine & International Health: TM & IH
2010; 15: 176–181.
Mahomed, OH, Asmall, S. Development and implementation of an integrated chronic disease model in South Africa: lessons in the management of change through improving the quality of clinical practice. International Journal of Integrated Care
2015; 15: e038.
de-Graft Aikins, A, Boynton, P, Atanga, LL. Developing effective chronic disease interventions in Africa: insights from Ghana and Cameroon. Globalization and Health
2010; 6: 6.
Aminkeng, F, et al.
Higher frequency of genetic variants conferring increased risk for ADRs for commonly used drugs treating cancer, AIDS and tuberculosis in persons of African descent. Pharmacogenomics Journal
2014; 14: 160–170.
Ramos, E, et al.
Pharmacogenomics, ancestry and clinical decision making for global populations. Pharmacogenomics Journal
2014; 14: 217–222.
Drain, PK, et al.
Diagnostic point-of-care tests in resource-limited settings. Lancet Infectious Diseases
2014; 14: 239–249.
Pai, NP, et al.
Barriers to implementation of rapid and point-of-care tests for human immunodeficiency virus infection: findings from a systematic review (1996–2014). Point of Care
2015; 14: 81–87.
Horton, R. Offline: chronic diseases – the social justice issue of our time. Lancet
2016: 386: 2378.
Collins, R. What makes UK Biobank special?
2012: 379: 1173–1174.